GPC1 and breast carcinoma: Of these, glycoprotein glypican – 1 (GPC1), which, although found circulating at low levels in healthy patients sera, was higher in patients with breast cancer (n = 32, 75%) and pancreatic ductal adenocarcinoma (PDAC, n = 190, 100%).